Skip to main content
Top

Clinical & Experimental Metastasis

Issue 5/2013

Content (14 Articles)

Research Paper

FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma

Michael L. Megison, Jerry E. Stewart, Hugh C. Nabers, Lauren A. Gillory, Elizabeth A. Beierle

Research Paper

Integrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis

Joseph L. Sottnik, Stephanie Daignault-Newton, Xiaotun Zhang, Colm Morrissey, Maha H. Hussain, Evan T. Keller, Christopher L. Hall

Research Paper

Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression

Kristy K. Ward, Isabelle Tancioni, Christine Lawson, Nichol L. G. Miller, Christine Jean, Xiao Lei Chen, Sean Uryu, Josephine Kim, David Tarin, Dwayne G. Stupack, Steven C. Plaxe, David D. Schlaepfer

Research Paper

Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer

Naohisa Futamura, Hiroshi Urakawa, Eisuke Arai, Eiji Kozawa, Naoki Ishiguro, Yoshihiro Nishida

Research Paper

Value of metastin receptor immunohistochemistry in predicting metastasis after radical nephrectomy for pT1 clear cell renal cell carcinoma

Sunao Shoji, Mayura Nakano, Tetsuro Tomonaga, Hakushi Kim, Kazuya Hanai, Yukio Usui, Yoshihiro Nagata, Masaki Miyazawa, Haruhiro Sato, Xian Yang Tang, Yoshiyuki Robert Osamura, Toyoaki Uchida, Toshiro Terachi, Koichi Takeya

Research Paper

Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model

Shawn P. Carey, Alina Starchenko, Alexandra L. McGregor, Cynthia A. Reinhart-King

Research Paper

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations

S. Bayraktar, A. M. Gutierrez-Barrera, H. Lin, N. Elsayegh, T. Tasbas, J. K. Litton, N. K. Ibrahim, P. K. Morrow, M. Green, V. Valero, D. J. Booser, G. N. Hortobagyi, B. K. Arun

Research Paper

Hypofractionated radiotherapy with Tomotherapy for patients with hepatic oligometastases: retrospective analysis of two institutions

Jong Hoon Lee, Joo Hwan Lee, Hong Seok Jang, Hyo Chun Lee, Jung Won Lee, Dae Gyu Kang, Byoung Yong Shim, Bong-Hyeon Kye, Hyung Jin Kim, Hyeon-Min Cho, Young Jin Suh, Sung Hwan Kim

Research Paper

Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma

Hongyuan Chen, Ruizheng Miao, Junwei Fan, Zhongbo Han, Junyi Wu, Guoqiang Qiu, Huamei Tang, Zhihai Peng

Research Paper

Ecto-5′-nucleotidase (CD73) promotes tumor angiogenesis

Li Wang, Shaoxian Tang, Yingjian Wang, Siguang Xu, Jerry Yu, Xiuling Zhi, Zhouluo Ou, Jiayin Yang, Ping Zhou, Zhimin Shao

Open Access Research Paper

Increased growth of colorectal liver metastasis following partial hepatectomy

P. Krause, H. Flikweert, M. Monin, A. Seif Amir Hosseini, G. Helms, G. Cantanhede, B. M. Ghadimi, S. Koenig

Review

In vivo animal models for studying brain metastasis: value and limitations

Inderjit Daphu, Terje Sundstrøm, Sindre Horn, Peter C. Huszthy, Simone P. Niclou, Per Ø. Sakariassen, Heike Immervoll, Hrvoje Miletic, Rolf Bjerkvig, Frits Thorsen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine